From: Accuracy validation of adjuvant! online in Taiwanese breast cancer patients - a 10-year analysis
 | Total N = 559 (%) |
---|---|
Age, years | 49.5 |
ER | Â |
Negative | 204 (36.5) |
Positive | 345 (61.7) |
Unknown | 10 (1.8) |
Grade | Â |
I | 130 (23.3) |
II | 204 (36.5) |
III | 105 (18.8) |
Unknown | 120 (21.5) |
Tumor Size | Â |
T1 | 235 (42.0) |
T2 | 285 (51.0) |
T3 | 39 (7.0) |
Node | Â |
N0 | 323 (57.8) |
N1 | 135 (24.2) |
N2 | 50 (8.9) |
N3 | 51 (9.1) |
Status | Â |
Died | 87 (15.6) |
Survived | 472 (84.4) |
Hormone therapy | Â |
Yes | 476 (85.2) |
No | 83 (14.8) |
Chemotherapy | Â |
Yes | 381 (68.2) |
No | 149 (26.7) |
Less than expected cycles | 29 (5.1) |